Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular diseases

Details for Australian Patent Application No. 2001288798 (hide)

Owner MCW Research Foundation, Inc. Taisho Pharmaceutical Co., Ltd.

Inventors Miyata, Noriyuki; Kameo, Kazuya; Okuyama, Shigeru; Harder, David R.; Roman, Richard J.; Sato, Masakazu

Agent Pizzeys

Pub. Number AU-B-2001288798

PCT Pub. Number WO02/36108

Priority 60/245,638 03.11.00 US

Filing date 6 September 2001

Wipo publication date 15 May 2002

Acceptance publication date 2 November 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/15 (2006.01) - Oximes (CNO)

A61K 31/20 (2006.01)

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

2 November 2006 Application Accepted

  Published as AU-B-2001288798

1 March 2007 Standard Patent Sealed

2 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001288799

2001288797